PMID- 19951957 OWN - NLM STAT- MEDLINE DCOM- 20100520 LR - 20171116 IS - 1460-2377 (Electronic) IS - 0953-8178 (Linking) VI - 22 IP - 2 DP - 2010 Feb TI - CD16/32-specific biotinylated 2.4G2 single-chain Fv complexed with avidin-FITC enhances FITC-specific humoral immune response in vivo in a CD16-dependent manner. PG - 71-80 LID - 10.1093/intimm/dxp115 [doi] AB - Fcgamma receptors (FcgammaRs) play an essential role in the regulation of immune response due to their ability to bind immune complexes. Activating FcgammaRs may facilitate antigen presentation and dendritic-cell maturation, while in the late phase of the immune response, the inhibitory FcgammaRIIb may down-regulate B-cell activation upon cross-linking with activating receptors. In this study, we investigated the in vivo role of FcgammaRs on the modulation of humoral immune response. In order to get well-defined immune complexes that can bind to both the activating and the inhibitory FcgammaRs, we designed a mono-biotinylated single-chain fragment variable construct from the rat anti-mouse CD16/32 clone 2.4G2, linked to avidin-FITC, and tested its effect on the FITC-hapten-specific T-independent type 2 (TI-2) and T-dependent (TD) immune response. When injected intravenously in mice, the complex bound to a small portion of B220+, CD11b(high) and CD11c(high) cells and was localized in the spleen on marginal zone macrophages 15 min after treatment. When applied as a booster following primary immunization with TI-2 (FITC-dextran) or TD (FITC-keyhole limpet haemocyanin) antigens, the complex elevated the number of hapten-specific IgM/IgG-producing B cells. This effect was diminished in CD16KO mice, suggesting that the activating-type FcgammaRIII might be a key mediator of this mechanism. FAU - Angyal, Adrienn AU - Angyal A AD - Department of Immunology, Eotvos Lorand University, 1117 Budapest, Hungary. FAU - Szekeres, Zsuzsanna AU - Szekeres Z FAU - Balogh, Peter AU - Balogh P FAU - Neer, Zsuzsa AU - Neer Z FAU - Szarka, Eszter AU - Szarka E FAU - Virag, Viktor AU - Virag V FAU - Medgyesi, David AU - Medgyesi D FAU - Prechl, Jozsef AU - Prechl J FAU - Sarmay, Gabriella AU - Sarmay G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20091130 PL - England TA - Int Immunol JT - International immunology JID - 8916182 RN - 0 (Cytokines) RN - 0 (Dextrans) RN - 0 (Fcgr2b protein, mouse) RN - 0 (Fcgr3 protein, mouse) RN - 0 (Receptors, IgG) RN - 0 (Recombinant Fusion Proteins) RN - 0 (Single-Chain Antibodies) RN - 0 (fluorescein isothiocyanate dextran) RN - 0 (fluorescein isothiocyante avidin) RN - 1405-69-2 (Avidin) RN - 9013-72-3 (Hemocyanins) RN - FV4Y0JO2CX (keyhole-limpet hemocyanin) RN - I223NX31W9 (Fluorescein-5-isothiocyanate) SB - IM MH - Animals MH - Antibody-Producing Cells/drug effects/*immunology MH - Avidin/*immunology MH - B-Lymphocytes/immunology MH - Biotinylation MH - Cytokines/metabolism MH - Dextrans/administration & dosage/immunology MH - Fluorescein-5-isothiocyanate/administration & dosage/*analogs & derivatives MH - Hemocyanins/administration & dosage/immunology MH - Hybridomas MH - *Immunity, Humoral/drug effects MH - Injections, Intravenous MH - Macrophages/immunology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Protein Binding MH - Rats MH - Receptors, IgG/deficiency/genetics/*immunology MH - Recombinant Fusion Proteins/immunology MH - Single-Chain Antibodies/administration & dosage/genetics/*immunology MH - Spleen/immunology MH - Time Factors EDAT- 2009/12/03 06:00 MHDA- 2010/05/21 06:00 CRDT- 2009/12/03 06:00 PHST- 2009/12/03 06:00 [entrez] PHST- 2009/12/03 06:00 [pubmed] PHST- 2010/05/21 06:00 [medline] AID - dxp115 [pii] AID - 10.1093/intimm/dxp115 [doi] PST - ppublish SO - Int Immunol. 2010 Feb;22(2):71-80. doi: 10.1093/intimm/dxp115. Epub 2009 Nov 30.